清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.

特雷姆2 临床痴呆评级 痴呆 阿尔茨海默病 神经影像学 生物标志物 PSEN1型 认知功能衰退 心理学 无症状的 阿尔茨海默病神经影像学倡议 医学 内科学 肿瘤科 疾病 病理 神经科学
作者
Estrella Morenas-Rodríguez,Yan Li,Brigitte Nuscher,Nicolai Franzmeier,Chengjie Xiong,Marc Suárez-Calvet,Anne M Fagan,Stephanie Schultz,Brian A Gordon,Tammie L S Benzinger,Jason Hassenstab,Eric McDade,Regina Feederle,Celeste M Karch,Kai Schlepckow,John C Morris,Gernot Kleinberger,Bengt Nellgard,Jonathan Vöglein,Kaj Blennow,Henrik Zetterberg,Michael Ewers,Mathias Jucker,Johannes Levin,Randall J Bateman,Christian Haass
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:21 (4): 329-341
标识
DOI:10.1016/s1474-4422(22)00027-8
摘要

Therapeutic modulation of TREM2-dependent microglial function might provide an additional strategy to slow the progression of Alzheimer's disease. Although studies in animal models suggest that TREM2 is protective against Alzheimer's pathology, its effect on tau pathology and its potential beneficial role in people with Alzheimer's disease is still unclear. Our aim was to study associations between the dynamics of soluble TREM2, as a biomarker of TREM2 signalling, and amyloid β (Aβ) deposition, tau-related pathology, neuroimaging markers, and cognitive decline, during the progression of autosomal dominant Alzheimer's disease.We did a longitudinal analysis of data from the Dominantly Inherited Alzheimer Network (DIAN) observational study, which includes families with a history of autosomal dominant Alzheimer's disease. Participants aged over 18 years who were enrolled in DIAN between Jan 1, 2009, and July 31, 2019, were categorised as either carriers of pathogenic variants in PSEN1, PSEN2, and APP genes (n=155) or non-carriers (n=93). We measured amounts of cleaved soluble TREM2 using a novel immunoassay in CSF samples obtained every 2 years from participants who were asymptomatic (Clinical Dementia Rating [CDR]=0) and annually for those who were symptomatic (CDR>0). CSF concentrations of Aβ40, Aβ42, total tau (t-tau), and tau phosphorylated on threonine 181 (p-tau) were measured by validated immunoassays. Predefined neuroimaging measurements were total cortical uptake of Pittsburgh compound B PET (PiB-PET), cortical thickness in the precuneus ascertained by MRI, and hippocampal volume determined by MRI. Cognition was measured using a validated cognitive composite (including DIAN word list test, logical memory delayed recall, digit symbol coding test [total score], and minimental status examination). We based our statistical analysis on univariate and bivariate linear mixed effects models.In carriers of pathogenic variants, a high amyloid burden at baseline, represented by low CSF Aβ42 (β=-4·28 × 10-2 [SE 0·013], p=0·0012), but not high cortical uptake in PiB-PET (β=-5·51 × 10-3 [0·011], p=0·63), was the only predictor of an augmented annual rate of subsequent increase in soluble TREM2. Augmented annual rates of increase in soluble TREM2 were associated with a diminished rate of decrease in amyloid deposition, as measured by Aβ42 in CSF (r=0·56 [0·22], p=0·011), in presymptomatic carriers of pathogenic variants, and with diminished annual rate of increase in PiB-PET (r=-0·67 [0·25], p=0·0060) in symptomatic carriers of pathogenic variants. Presymptomatic carriers of pathogenic variants with annual rates of increase in soluble TREM2 lower than the median showed a correlation between enhanced annual rates of increase in p-tau in CSF and augmented annual rates of increase in PiB-PET signal (r=0·45 [0·21], p=0·035), that was not observed in those with rates of increase in soluble TREM2 higher than the median. Furthermore, presymptomatic carriers of pathogenic variants with rates of increase in soluble TREM2 above or below the median had opposite associations between Aβ42 in CSF and PiB-PET uptake when assessed longitudinally. Augmented annual rates of increase in soluble TREM2 in presymptomatic carriers of pathogenic variants correlated with decreased cortical shrinkage in the precuneus (r=0·46 [0·22]), p=0·040) and diminished cognitive decline (r=0·67 [0·22], p=0·0020).Our findings in autosomal dominant Alzheimer's disease position the TREM2 response within the amyloid cascade immediately after the first pathological changes in Aβ aggregation and further support the role of TREM2 on Aβ plaque deposition and compaction. Furthermore, these findings underpin a beneficial effect of TREM2 on Aβ deposition, Aβ-dependent tau pathology, cortical shrinkage, and cognitive decline. Soluble TREM2 could, therefore, be a key marker for clinical trial design and interpretation. Efforts to develop TREM2-boosting therapies are ongoing.German Research Foundation, US National Institutes of Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Galaxy完成签到,获得积分10
30秒前
好运连连关注了科研通微信公众号
43秒前
隐形曼青的应助被科研通管家采纳,获得10
48秒前
ChencanFang完成签到,获得积分10
1分钟前
楚科研完成签到 ,获得积分10
1分钟前
潇洒小海豚完成签到,获得积分10
1分钟前
奔跑的应助被Jianing采纳,获得30
2分钟前
NexusExplorer的应助被11采纳,获得10
2分钟前
姚老表发布了新的文献求助30
2分钟前
2分钟前
乐乐的应助被GraceKabiri759采纳,获得30
3分钟前
3分钟前
好运连连发布了新的文献求助10
3分钟前
3分钟前
3分钟前
Agan发布了新的文献求助10
3分钟前
把饭拼好给你完成签到 ,获得积分10
3分钟前
思源的应助被Agan采纳,获得10
4分钟前
好运连连完成签到,获得积分10
4分钟前
4分钟前
4分钟前
五月完成签到,获得积分10
4分钟前
瘦瘦的枫叶完成签到 ,获得积分10
4分钟前
sugar发布了新的文献求助10
4分钟前
传奇3的应助被wuyy采纳,获得10
4分钟前
酷波er的应助被sugar采纳,获得10
4分钟前
Omarkyarm完成签到,获得积分10
5分钟前
5分钟前
wuyy发布了新的文献求助10
5分钟前
圆月弯刀完成签到 ,获得积分10
5分钟前
合适乐巧完成签到 ,获得积分10
5分钟前
null的应助被mashibeo采纳,获得10
5分钟前
wuyy完成签到,获得积分20
5分钟前
赘婿的应助被wuyy采纳,获得10
5分钟前
5分钟前
wuyy发布了新的文献求助10
6分钟前
JUN完成签到,获得积分10
6分钟前
6分钟前
瞿人雄完成签到,获得积分10
6分钟前
没心没肺完成签到,获得积分10
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195184
求助须知:如何正确求助?哪些是违规求助? 9580915
关于积分的说明 21872990
捐赠科研通 7795171
什么是DOI,文献DOI怎么找? 3437967
关于科研通互助平台的介绍 2561276
邀请新用户注册赠送积分活动 2484678